These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3686902)

  • 1. [Study of intralysosomal protein catabolism using lysosomotropic agents--proteolysis and protease inhibitors].
    Korolenko TA; Pupyshev AB; Mudrakovskaia AV
    Vopr Med Khim; 1987; 33(5):93-6. PubMed ID: 3686902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of single and repeated administration of chloroquine on the activity of lysosomal proteinases in rat liver cells].
    Korolenko TA; Rukavishnikova EV; Pupyshev AB
    Vopr Med Khim; 1990; 36(6):20-3. PubMed ID: 2075715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterophagic function and rate of intralysosomal proteolysis during lysosomotropic agents administration.
    Korolenko TA; Pupyshev AB; Malygin AE
    Acta Biol Med Ger; 1981; 40(10-11):1613-7. PubMed ID: 7342605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocytosis by liver cells during suppression of intralysosomal proteolysis.
    Korolenko TA; Rukavishnikova EV; Safina AF; Dushkin MI; Mynkina GI
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):573-80. PubMed ID: 1515086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of the effect of effectors on proteinases from rat liver lysosomes in vitro].
    Salama ZB
    Acta Biol Med Ger; 1980; 39(4):355-66. PubMed ID: 7445886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Facilitation of the structural and functional disorders of liver lysosomes in toxic hepatitis due to the suppression of intralysosomal proteolysis].
    Korolenko TA; Pupyshev AB; Malygin AE; Gavrilova NI; Kurysheva NG
    Biull Eksp Biol Med; 1985 Aug; 100(8):169-72. PubMed ID: 3896340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The lysosomal proteolytic system and thyroid functional activity in rats administered chloroquine].
    Stroev EA; Kochukov MIu; Nikolaev VV
    Eksp Klin Farmakol; 1997; 60(4):50-2. PubMed ID: 9376759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chloroquine on the form and function of hepatocyte lysosomes. Morphologic modifications and physiologic alterations related to the biliary excretion of lipids and proteins.
    Sewell RB; Barham SS; LaRusso NF
    Gastroenterology; 1983 Nov; 85(5):1146-53. PubMed ID: 6413291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chloroquine on lysosomes and endocytosis by liver cells in vivo.
    Korolenko TA; Rukavishnikova EV; Safina AF; Mynkina GI; Vereshchagin EI
    Acta Biol Hung; 1991; 42(1-3):301-9. PubMed ID: 1844318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
    Schneider P; Korolenko TA; Busch U
    Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the lysosomal apparatus during differentiation of cultured striated muscle cells.
    McElligott MA; Roisen FJ; Keaton KS; Triemer DF; Li QS; St John AC; Yorke G; Bird JW
    Acta Biol Med Ger; 1981; 40(10-11):1333-47. PubMed ID: 7043998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple preparation of rat brain lysosomes and their proteolytic properties.
    Ohshita T; Kido H
    Anal Biochem; 1995 Sep; 230(1):41-7. PubMed ID: 8585628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to lysosomotropic amines and protease inhibitors retard corneal endothelial cell migration along the natural basement membrane during wound repair.
    Gordon SR; DeMoss J
    Exp Cell Res; 1999 Jan; 246(1):233-42. PubMed ID: 9882532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decrease in the rats of intraliposomal proteolysis and labilization of rat liver lysosomes following suramin administration].
    Korolenko TA; Pupyshev AB; Malygin AE
    Biull Eksp Biol Med; 1980 Dec; 90(12):686-8. PubMed ID: 6781552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal thiol cathepsins and their endogenous inhibitors. Distribution and localization.
    Katunuma N; Kominami E
    Prog Clin Biol Res; 1985; 180():71-9. PubMed ID: 3898124
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of cycloheximide on lysosomal proteinase activity in rat organs].
    Vasil'ev AV; Nepesova ShA; Tutel'ian VA
    Biull Eksp Biol Med; 1983 Jul; 96(7):39-40. PubMed ID: 6135463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of a cysteine proteinase inhibitor, EST, in experimental chloroquine myopathy in rats.
    Sugita H; Higuchi I; Sano M; Ishiura S
    Muscle Nerve; 1987; 10(6):516-23. PubMed ID: 3306368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of silimarine on activity of lysosomal proteinases in the liver and kidneys during tetramethylthiuram disulfide administration].
    Tabagari SI; Shubitidze TM; Abdushelishvili GV
    Vopr Med Khim; 1988; 34(5):110-3. PubMed ID: 3064406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal and dietary regulation of lysosomal cysteine proteinases in liver under gluconeogenesis conditions.
    Inubushi T; Shikiji M; Endo K; Kakegawa H; Kishino Y; Katunuma N
    Biol Chem; 1996; 377(7-8):539-42. PubMed ID: 8922290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autodegradation of lysosomal cysteine proteinases.
    Kominami E; Tsukahara T; Bando Y; Katunuma N
    Biochem Biophys Res Commun; 1987 Apr; 144(2):749-56. PubMed ID: 3555495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.